(C) Immunoprecipitation of the endogenous Squ from ovarian lysate revealed the interaction with Spn-E protein. Proteins were detected by western blotting analysis using the specific antibody for each ...

Thermo Fisher's Q3 numbers just dropped, and while revenue hit $10.60 billion (a slight uptick from Q2), it's flat compared ...

The global gene editing market is expected to reach USD 7.59 billion in 2029 from USD 4.66 billion in 2024, at a CAGR of 10.2 ...

WALTHAM, Mass., November 15, 2024--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors has authorized the ...

Adaptimmune’s Phase II IGNYTE-ESO trial investigating experimental T cell therapy lete-cel has achieved its primary endpoint.

Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock ...

Thermo Fisher Scientific Inc. is one of the leading providers of medical equipment, analytical instruments, reagents & consumables, software, and services. Through its Life Science Solutions segment, ...

Key Players: Prominent market players include Bio-Rad Laboratories, Chembio Diagnostics, Enfer, IDEXX Laboratories, IDVet, LIONEX, PBD Biotech, QIAGEN, Thermo Fisher Scientific, and ZENDAL. These ...

McDonald’s Corp. sold its first Swiss franc-denominated bond since 2016, with the deal coming in the wake of an E. coli outbreak and disappointing third-quarter results.

The offering comes two weeks after McDonald’s reported sales that fell short of Wall Street’s expectations amid weakness in ...